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Peroxisomal  P-oxidation  of linoleic acid and arachi- 
donic acid was depressed when l-palmitoyl-sn-glycero- 
3-phosphocholine and microsomes  were included in in- 
cubations.  This reduction was due to the esterification 
of the substrate into the acceptor by  microsomal l-acyl- 
sn-glycero-3-phosphocholine acyltransferase. The first 
cycle of the @-oxidation of 7,10,13,16-docosatetraenoic 
acid was independent of l-acyl-sn-glycero-3-phospho- 
choline and microsomes.  However,  when  arachidonate 
was produced it was esterified rather than serving as a 
substrate for continued P-oxidation. When arachidonate 
and linoleate were incubated with peroxisomes alone, 
2-trans-4,7,1O-hexadecatetraenoic acid and 2-trans-4-de- 
cadienoic acid were the respective end products of 
@-oxidation. 2-0~0-8,11-heptadecadienone, a catabolite 
produced from linoleate, was most likely a nonenzy- 
matic  decarboxylation  product  of  3-oxo-9,12-octadecadi- 
enoic acid. In addition to the termination  of  P-oxidation 
by  microsomal-peroxisomal  communication,  our results 
with linoleate and arachidonate suggest that the reac- 
tion catalyzed by 2-trans-4-cis-dienoyl-CoA reductase is 
the control step in double  bond  removal.  In addition, the 
@-ketothiolase step may play a regulatory role in the 
peroxisomal @-oxidation of linoleate but not arachido- 
nate or 7,10,13,16-docosatetraenoic acid. 
Hepatic biosynthesis of PUFA,’ from dietary  precursors, is a 
microsomal process that proceeds via alternating position-spe- 
cific acyl-CoA desaturases  and malonyl-CoA-dependent chain 
elongation reactions (1). Catabolism of PUFA, via the P-oxida- 
tion  spiral,  may  take place in both  mitochondria and peroxi- 
somes. A generally accepted role for peroxisomes is to  chain- 
shorten long-chain fatty  acids which may  then be transported 
to mitochondria where  the process is completed (2-4).  Under 
normal physiological conditions,  mitochondrial P-oxidation, 
once initiated, is generally  thought to proceed to completion 
with  little if any accumulation of chain-shortened products. 
Biosynthesis and catabolism of PUFA are  thus two totally  sepa- 
rate processes that  are  compartmentalized  within  the cell. 
It  has, however, long  been recognized that  in  the  intact  ani- 
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mal long-chain PUFA are  partially P-oxidized with  the  esteri- 
fication of chain-shortened  intermediates  into  membrane lip- 
ids.  When 4,7,10,13,16-225 (5) and 7,10,13,16-22:4 (6) were fed 
to rats raised on a fat-free diet,  there  was a large  increase of 
esterified arachidonate  in  hepatic lipids.  When [3-14C]10,13,16- 
22:3 was  administered  to  rats,  it  was possible to detect  esteri- 
fied arachidonate  in  both mitochondrial and microsomal phos- 
pholipids (7). The  implication of this finding  is  that 
[3-’4C110,13,16-22:3 is 0-oxidized to  [1-14C]8,11,14-20:3 which 
then moves to  the endoplasmic reticulum  where it is desatu- 
rated  to  arachidonate.  The physiological relevance of this  ap- 
parent  intracellular movement of fatty acids  between the  en- 
doplasmic reticulum  and a site for P-oxidation was  not 
apparent  in  these  early  studies. 
We recently refuted  the commonly accepted, but  untested, 
hypothesis that  desaturation of 7,10,13,16,19-22:5 to 4,7, 
10,13,16,19-22:6 is catalyzed by a microsomal acyl-CoA-de- 
pendent  4-desaturase.  In  these  studies, we showed that 
7,10,13,16,19-225  was  the  precursor for 4,7,10,13,16,19-22:6, 
but the pathway proceeded as follows: 7,10,13,16,19-225 - 
22:6. The first two reactions take place in the endoplasmic 
reticulum followed by the  transfer of 6,9,12,15,18,21-24:6 to a 
site for partial P-oxidation where it is chain-shortened to 
4,7,10,13,16,19-22:6 (8). Recent studies  have shown that 
7,10,13,16-22:4 is metabolized  to 4,7,10,13,16-22:5 via an  anal- 
ogous pathway.2 
Martinez (9) reported that liver  phospholipids of a patient 
with Zellweger’s disease contained low levels of esterified 
4,7,10,13,16-225 and 4,7,10,13,16,19-22:6. These composi- 
tional findings suggest  that peroxisomes are  required for the 
synthesis of these two fatty acids from dietary precursors. 
When [3-14C17,10,13,16-22:4 was incubated with rat  hepato- 
cytes or injected into  the tail vein of rats,  its  primary anabolic 
fate was partial P-oxidation to arachidonate followed by its 
esterification into phospholipids  (10). Fibroblasts from control 
patients metabolized [3-’4C]7,10,13,16-22:4 to yield esterified 
arachidonate. Conversely, fibroblasts from a Zellweger’s pa- 
tient did not  metabolize the  substrate  to yield any esterified 
arachidonate.  Both cells, however, metabolized the substrate 
into radioactive  water-soluble compounds (11). Collectively, the 
results  suggest  that  the  partial P-oxidation process is confined 
to peroxisomes. 
In  the  study  reported  here, we compare the  rates of p-oxida- 
tion of l-I4C- versus 3-14C-labeled 7,10,13,16-22:4 and show di- 
rect  intracellular communication  between peroxisomes and mi- 
crosomes in that  the  primary metabolic fate of arachidonate  is 
esterification into exogenously added l-acyl-GPC rather  than 
continued P-oxidation. 
9,12,15,18,21-24:5 3 6,9,12,15,18,21-24~6 * 4,7,10,13,16,19- 
* B. S. Mohammed, S. Sankarappa, and  H.  Sprecher,  manuscript in 
preparation. 
18390 
Intracellular  Communication  between  Microsomes  and Peroxisomes 18391 
EXPERIMENTAL PROCEDURES 
Materials-ATP, NADH, CoASH, Hepes,  dithiothreitol,  TES, NADP', 
NAD+, and  essentially  fatty  acid-free bovine serum  albumin  were from 
Sigma.  Antimycin A, lactate  dehydrogenase,  and Nycodenz (Accudenz) 
were obtained respectively from Fluka, Boehringer Mannheim, and 
Accurate Chemical and Scientific Corp. All phospholipids were pur- 
chased from Avanti  while linoleic, arachidonic,  and 7,10,13,16-docosa- 
tetraenoic acid were from Nu-Check Prep. [U-'4C1Linoleic acid and 
5,6,8,9,11,12,14,15-[3H1arachidonic acid were from DuPont  NEN  while 
[l-'4C]linoleic acid,  [l-'4Clarachidonic  a id, [1-l4C1- and [3-l4C1 
7,10,13,16-docosatetraenoic acid, 4-decenoic acid, 5,84etradecadienoic 
acid, 7,lO-hexadecadienoic acid,  4,7 10-hexadecatrienoic  ac d, 
17,17,18,18-d4-linoleic acid, and 19,19,20,20-d4-arachidonic a id were 
made by total  synthesis (12-14). 
Isolation of Peroxisomes and  Microsomes from Rat Liuer-Male 
Sprague-Dawley rats were  maintained on a chow diet  containing 0.5% 
clofibrate  (prepared by Dyets,  Bethlehem, PA) for 8 days  prior to  being 
sacrificed.  Peroxisomes  were  isolated in essence as described by Das  et 
al. (15). Liver  was homogenized in 0.25 M sucrose, 0.1 mM EDTA, 0.1% 
ethanol,  10 mM TES,  pH 7.5. The  nuclei  and  mitochondria  obtained by 
centrifugation a t  600 x g for 10  min  and 3300 x g for 10 min were 
discarded.  The  light  mitochondrial  pellet that  sedimented at 25,000 x g 
for 10  min  was  washed  with  the omogenizing buffer and  recentrifuged 
a t  25,000 x g for 10 min.  This  light  mitochondrial  fraction  was  resus- 
pended in  the homogenizing  medium in a  volume  corresponding to 1 
ml/g liver. Two ml of this  suspension  were  layered on 15 ml of 35% 
Nycodenz (w/v) containing 10 mM TES, 0.1% ethanol,  and  0.1 mM EDTA, 
pH 7.5, and centrifuged at 56,000 x g for 50 min.  The  peroxisomal  pellet 
was  suspended  in  the  incubation  medium  which  contained  130 mM KCl, 
20 mM Hepes,  pH 7.2, and  the  protein  concentration  was  adjusted  to  3 
mg/ml using  the Coomassie Blue  reagent  (Pierce  Chemical Co.) to  assay 
protein.  The  purity of the peroxisomes was  determined by marker  en- 
zyme analysis  using  catalase for peroxisomes (16), glucose-6-phospha- 
tase for microsomes (17),  and  succinate cytochrome c-reductase for mi- 
tochondria  (18).  The  relative specific activities  (average of six 
determinations * S.D.) for glucose-6-phosphatase and succinate cyto- 
chrome  c-reductase  in peroxisomes relative  to  the  total  liver homoge- 
nate were, respectively, 1.45 * 0.31 and 0.21 * 0.08. The activity of 
catalase in peroxisomes was  1486 f 372 unitdmg of peroxisomal pro- 
tein.  In  order  to  prepare microsomes, the 25,000 x g supernatant  was 
centrifuged at 110,000 x g for 45 min.  The microsomal pellet  was re- 
suspended  in a medium  containing  0.6 M KCI, 0.1 M phosphate,  pH 7.4, 
and  the  microsomal  pellet  obtained by centrifugation at 110,000 x g for 
45  min  was  suspended  in  130 mM KC1,20 mM Hepes,  pH 7.2, and  stored 
at -80 "C (19). 
Peroxisomal p-Oxidation-Peroxisomes (300 pg of proteidml)  were 
incubated at  37 "C in a shaking  water  bath  in a medium  that  contained 
130 mM KCI, 20 mM Hepes,  0.1 mM EGTA, 0.5 mM NAD+, 0.1 mM NADP+, 
0.1 mM dithiothreitol, 0.2 mM CoASH, 10 mM Mg2+ATP, 20 mM pyruvate, 
10 pg of antimycin,  and  2  units of lactate  dehydrogenase  (20).  Reactions 
were  initiated by the  addition of the sodium  salt of the  fatty acid (2 
Ci/mol) that  was bound  to bovine serum  albumin  in a 2:l  molar  ratio. 
Aliquots of 200 p1 were removed and  added  to  an  equal volume of 5% 
HClO,. After 30 min at 4 "C, the  samples  were  centrifuged  and 200 p1 
was  counted  to  measure acid-soluble radioactivity.  Other  incubations 
also  contained  100  p~ 1-acyl-GPC and 300  pg of microsomal protein. 
After 30 min,  the  reactions  were  terminated by addition of 1.7  ml of 
MeOH and 3.4 ml of CHCl,. The  tubes  were  centrifuged,  the bottom 
organic  layer  was  taken  to  dryness,  and  the  neutral  lipids  were  sepa- 
rated from phospholipids by sequential elution of Pasteur pipettes 
packed with Unisil (Clarkson Chemical Co., Williamsport, PA) with 
CHCl, and MeOH. The MeOH was removed under N,, 1 ml of CHCl,/ 
MeOH was  added,  and  an  aliquot  was  counted.  A second aliquot  was 
applied to a Whatman LK5 plate which was developed with CHCld 
MeOH/40% methylamine (65:25:5, v/v) (21).  The zones corresponding  to 
various  phospholipids  were  scraped  into  scintillation  vials for counting. 
The  remainder of the  total  phospholipids  was  interesterified by stirring 
them  overnight  with  anhydrous 5% HCl in MeOH. The  methyl  esters 
were  separated by HPLC by eluting a 0.46 x 25 cm Zorbax ODS column 
with  acetonitrile/water (90:10, v/v) at 1 ml  per  min.  The  effluent  was 
mixed with  ScintiVerse LC (Fisher) (3 mumin),  and  radioactivity  was 
detected  with a Beckman  171  radioisotope  detector. 
bated  with either 100 p~ [U-'4C]linoleic acid (2 Ci/mol) or 
Metabolite Isolation and Characterization-Peroxisomes were  incu- 
[5,6,8,9,11,12,14,15-3H]arachidonic acid (10 Ci/mol). After 30  min,  the 
incubations  were  terminated by addition of 0.25  ml of 4 N NaOH  and  1.7 
ml of MeOH. The  contents  were  stirred  overnight, acidified with  6 N 
"1 A 
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[1-14C]5,8,11,14-204 (B) ,  [1-14C17,10,13,16-224 ( 0 ,  and [3-"Cl 
FIG. 1. The time-dependent /3-oxidation of [1-'4C19,12-182 (A), 
7,10,13,16-22:4 (D) .  Peroxisomes  (300  pg of proteidml)  were  incubated 
alone  with 50 (0) or 100 (0) p~ concentrations of fatty  acids  as well as 
when  incubations  with  100  p~  levels of fatty  acids  also  contained 100 p~ 
are described  under "Experimental  Procedures." At the indicated  times, 
1-acyl-GPC and 300 pg of microsomal protein (A). Incubation conditions 
200 pl was removed and added to 200 pl of cold 5% HC10,. After 
centrifugation, 200 pl of the  supernatant  was  used  to  measure acid- 
soluble  radioactivity. 
HCl, and 3.4  ml of CHCl, was  added.  The  bottom  layer  was  taken  to 
dryness,  and  the  residue  was  reacted  with 5% anhydrous HC1 in MeOH. 
The  radioactivity  was then monitored by HPLC by eluting  the column 
with acetonitrile/H,O (8515, v/v). Large-scale incubations were then 
carried  out  using 17,17,18,18-d4-linoleic acid and  19,19,20,20-d4-arachi- 
donic acid. Appropriate  fractions  were collected from the column efflu- 
ent,  the acetonitrile  was removed under N,, and  metabolites  were  re- 
covered by extraction  with 20% diethyl  ether  in  petroleum  ether.  Trace 
amounts of water were removed by passing the combined extract 
through  a  Pasteur  pipette packed with  granular Na,SO,. The  solvent 
was removed under N,, and  the compounds  were dissolved in iso-octane 
with a Hewlett-Packard Model 5970A mass selective detector and a 
and  analyzed by mass  spectrometry.  Mass  spectrometry  was  carried  out 
5770 gas  chromatograph  containing a 30-m x 0.25-mm,  inside  diameter, 
DB-225 column (J and  W Scientific). Injections  were  made  in the  split- 
less mode at  70 "C, and, after 3 min, the oven was programmed to 
185 "C a t  15 Wmin. 
RESULTS 
The  results  in Fig. 1 compare the time-dependent rates of 
P-oxidation when peroxisomes were incubated with  either 50 
p~ (0) or 100 p~ (0) [1-'4C19,12-18:2 (A), [1-'4C15,8,11,14-20:4 
( B ) ,  [1-14C]7,10,13,16-22:4 (C), or [3-'4C17,10,13,16-22:4 (Dl .  At 
5 min,  the  rates of P-oxidation of all three l-14C-labeled sub- 
strates were greater when the  higher level of substrate was 
used. In  the  latter case, the nanomoles of acid-soluble radioac- 
tivity produced at 5 min from 100 p~ [1-'4C]9,12-18:2, 
[1-'4C15,8,11,14-20:4, and [1-'4C17,10,13,16-22:4 were thus, re- 
spectively, 40,11,  and 31. Arachidonic acid was a comparatively 
poor substrate for peroxisomal P-oxidation as was previously 
reported (22). The nonlinearity, in  the  apparent time-depend- 
ent  rate of P-oxidation, was  due both to  substrate depletion and 
the  generation of unlabeled chain-shortened products which 
continue to  serve as substrates for the P-oxidation spiral. When 
the  rate of two cycles of P-oxidation was  assayed using 
[3-'4C17,10,13,16-22:4, the  amount of acid-soluble radioactivity 
produced was relatively independent of substrate concentra- 
tion (Fig. MI) .  
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TABLE I 
The percent of radioactivity  in  indiuidual  phospholipids 
Whatman LK5 plates which were developed with CHCl@eOW40% 
Phospholipids were separated by thin layer chromatography using 
methylamine (65:25:5, v/v) (21). The  zones  corresponding  to  authentic 
phospholipids  were  scraped into scintillation vials and  counted. 
Phospholipid [l-"CI [l-"Cl [3-"C1 
~~ 
9,12-182 5,8,11,14-20:4 7,10,13,16-22:4 
Phosphatidylethanolamine 2.7  5.6  10.6 
Phosphatidylcholine 92.5  88.5  83.0 
Sphingomyelin 2.9  2.5 
Phosphatidylserine 1.0  1.1 1.4 
3.0 
Phosphatidylinositol 0.8  2.3  2.0 
When the four substrates (100 p ~ )  were now incubated  with 
100 p~ 1-acyl-GPC and 300 pg of microsomal protein (A), there 
was a decline in the  amount of acid-soluble radioactivity pro- 
duced from [1-'4C]9,12-18:2, [1-'4C]5,8,11,14-20:4, and 
[3-14C17,10,13,16-22:4. The  rate of P-oxidation of  [1-14C] 
7,10,13,16-22:4 was  not  depressed by addition of 1-acyl-GPC 
and microsomes. 
Incubations  after  30  min  with  the four substrates  and l-acyl- 
GPC and microsomes were then  extracted  as  per Folch et ul. 
(23).  When [1-14C19,12-18:2,  [1-'4C15,8,11,14-20:4, [3-14C] 
7,10,13,16-22:4, and [1-14C]7,10,13,16-22:4 were the  substrates, 
the  amount of radioactivity recovered in  the bottom layer was, 
respectively, 68, 82, 62, and 15% of what was added to the 
incubations. 
In essence, all of the radioactivity in  the bottom organic layer 
was esterified into phospholipids. This  was  established  either 
by sequentially  eluting  the  lipids from a Unisil column with  10 
ml of CHC1, and  10  ml of MeOH or by chromatographing an 
aliquot of total lipids  on Whatman LK5 plates  using  diethyl 
ether/hexane/acetic  acid (70:30:1, v/v). More than 95% of the 
radioactivity was  in  the MeOH eluate  or  remained at the origin 
of the thin layer  plate. 
The  results  in Table I tabulate  the  percent of radioactivity in 
individual phospholipids when they were separated by thin 
layer  chromatography from those  incubations  containing l-14C- 
labeled  linoleate  or arachidonate  and [3-'4C17,10,13,16-22:4. As 
expected, the  majority of the radioactivity co-migrated with 
choline phosphoglycerides, thus showing that  the exogenously 
added acceptor was esterified. When [1-'4C15,8,11,14-20:4 or 
[3-'4C]7,10,13,16-22:4 was  the  substrate,  small  amounts of ra- 
dioactivity  co-migrated with  ethanolamine phosphoglycerides 
suggesting  that microsomes may  have contained trace  amounts 
of 1-acyl-sn-glycero-3-phosphoethanolamine. The total phos- 
pholipids  were now interesterified,  and  the  methyl  esters were 
analyzed by HPLC. When [1-'4C19,12-18:2 was  the  substrate, 
over 97% of the  esterified radioactivity co-migrated with 
methyl linoleate. In a similar way when [1-14C15,8,11,14-20:4 
was  the  substrate,  again over 97% of the radioactivity had a 
retention  time  identical  with  arachidonate. Conversely, when 
[3-'4C]7,10,13,16-22:4 was  the  substrate, 77%  of the  esterified 
radioactivity was  arachidonate  and 19% was 7,10,13,16-22:4. 
These  results show that when [1-14C19,12-18:2 and 
[1-14C]5,8,11,14-20:4 were the  substrates  the reduced rates of 
P-oxidation were due to esterification of the substrate into 
1-acyl-GPC. The  rate of the  first cycle of 7,10,13,16-22:4 P-oxi- 
dation  was  in essence independent of exogenous 1-acyl-GPC. As 
soon as arachidonate  was produced, its primary metabolic fate 
was esterification into the acceptor rather than continued 
P-oxidation. 
When [3-14C]7,10,13,16-22:4 was  incubated  with peroxi- 
somes, the only radioactive  metabolite that was detected was 
arachidonate.  The  results  in Fig. 2 show the  time-dependent 
@-oxidation of 7,10,13,16-22:4 and  the accumulation of arachi- 
-n 80 
0 5 10 20 30 
minutes 
FIG. 2. The time-dependent disappearance of 7,10,13,16-22:4 
when peroxisomes  were incubated with either 50 (A) or  100 p~ 
(A) [1-14C]7,10,13,16-22:4 uersus the accumulation of labeled 
arachidonate when peroxisomes were incubated with 60 (0) or 
100 (0) p~ [3-14C]7J0,13,16-224 
donate. The results clearly show that arachidonate accumu- 
lates  thus potentially making it available for movement out of 
the peroxisomes for use as a substrate for membrane lipid 
biogenesis. However, the  results  in Fig. 1 also show that when 
[1-'4C15,8,11,14-20:4 was  incubated alone with peroxisomes it 
was P-oxidized although a t  a relatively slow rate. To determine 
what products  were generated by P-oxidation of arachidonate, 
peroxisomes were incubated  with 100 p~ tritium-labeled 
arachidonic acid. When the methyl esters were analyzed by 
HPLC, it  was not possible to  detect  any radioactive compound 
where we would expect to find 18-carbon compounds. Only two 
radioactive compounds were  detected with  the  latter compound 
having a retention time identical with methyl 4,7,10-16:3. 
These two compounds were then  isolated from incubations  that 
were carried  out  with 19,19,20,20-d4-5,8,11,14-20:4. When the 
latter  eluting compound, from HPLC, was analyzed by GC-MS, 
its retention  time  was  identical  with  methyl 4,7,10-16:3 (16.5 
min) and it could be identified, from its mass spectrum, as 
methyl 15,15,16,16-d4-4,7,10-16:3. The  earlier  eluting more po- 
lar compound had a retention  time of 19.0 min  when analyzed 
by  GC-MS and  it  had  small ions at m / z  = 266 (1%) and at m / z  
= 234 (M - 32; 1%). It  is  thus most  likely methyl 15,15,16,16- 
d4-2-trans-4,7,10-16:4. 
As shown in Fig. 3, a more complex radiochromatogram was 
obtained  when  the products of an incubation with peroxisomes 
and [U-14C19,12-18:2 were separated by HPLC. Compounds 1, 
2, 3,  and 5 co-eluted, respectively, with  the  methyl  esters of 
4-10:1, 3,6-12:2, 5,8-14:2, and 7,lO-16:2. These metabolites 
were then isolated from incubations  carried  out  with 
17,17,18,18-d4-9,12-18:2. When  fraction 1 was analyzed by 
GC-MS, it was resolved into two compounds with  the  faster 
eluting component  being methyl 9,9,10,10-d4-4-10:l. The  mass 
spectrum of the second compound had an ion at m l z  = 186 
(20%) as well as  at  155 (M - 31; 15%) and  thus  is most  likely 
methyl 9,9,10,10-d4-2-truns-4-10:2. When  metabolite 4 was 
analyzed by GC-MS, its  spectrum  had a small ion at m / z  = 254 
(3%) with a base  peak at m / z  = 43  and no other ions of apparent 
diagnostic  value.  When this compound was analyzed by thin 
layer chromatography using hexane/diethyl ethedacetic acid 
(70:30:1, v/v), it co-migrated with  authentic 2-oxo-heptadeca- 
none. It  was  then derivatized by reaction with methoxamine- 
HC1 which, when analyzed by GC-MS, gave two closely eluting 
compounds as would be expected for syn and anti forms of a 
ketone. The  mass  spectrum of the  latter compound, as shown in 
Fig. 4,  had a molecular ion at m / z  = 283 as well as ions a t  m / z  
= 268 (M - 15) and 252 (M - 31). By comparing this spectrum 
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Minutes 
FIG. 3. A radiochromatogram showing the products of an in- 
cubation when peroxisomes (300 pg of proteidml) were incu- 
bated with 100  [U-'4C]9,12-182. After 30 min, the  incubation was 
terminated, and methyl esters were made  and separated by HPLC as 
described under  "Experimental  Procedures." 
Moss/Charge 
FIG. 4. The mass spectrum of the methyloxime derivative of 
metabolite 4 after incubating peroxisomes with 17,17,18,18-d4- 
9,12-182. 
with that of the methyloxime derivative of synthetic 2-oxo- 
7,10,13-nonadecatrienone, it was possible to  assign its struc- 
ture  as 16,16,17,17-d4-2-oxo-8,ll-heptadecadienone. 
DISCUSSION 
I t  is generally accepted that peroxisomes function to  chain- 
shorten  fatty acids which then move to  the mitochondria where 
the process is completed (2-4).  The  termination of peroxisomal 
fatty acid P-oxidation may be regulated more by competing 
reactions within the cell than by an absolute chain length- 
specific block in  the P-oxidation spiral. When peroxisomes were 
incubated  with [U-14Clpalmitic acid, the complete homologous 
series of chain-shortened intermediates, including hexanoyl- 
CoA, was detected  (20). Hexanoyl-CoA is a substrate for fatty 
acid  oxidase  (24).  Peroxisomes thus  have  the ability to  totally 
P-oxidize palmitic acid. In  the  study  reported  here, we show 
that  the  depressed  rate of P-oxidation of [1-'4C19,12-18:2 and 
[1-14C15,8,11,14-20:4, when peroxisomes were incubated with 
1-acyl-GPC and microsomes, is due to  the esterification of the 
substrate  into  the acceptor. By comparing the metabolism of 
l-14C- versus 3-I4C-labeled 7,10,13,16-22:4, it  was possible to 
show that  the  primary metabolic fate of arachidonate,  when  it 
was produced, was esterification into  the acceptor rather  than 
continued P-oxidation. Lands  et al. (25) reported  that  the V, 
values for acylation of arachidonate  and 7,10,13,16-22:4 into 
1-acyl-GPC were, respectively, 72 and 5 nmoVmidmg of rat 
liver  microsomal protein. When 7,10,13,16-22:4 was  incubated 
alone with peroxisomes, it was  rapidly P-oxidized. When  mi- 
crosomes and l-acyl-GPC were now added  to  the  incubation, 
only small  amounts of substrate were removed via  esterifica- 
tion,  and,  thus,  the  rate of 0-oxidation was not  depressed. How- 
ever, when  arachidonate  was produced via @-oxidation, it was 
preferentially  transported  out of peroxisomes for  esterification 
rather  than for continued P-oxidation. 
The  types of products that  accumulate  when peroxisomes are 
incubated alone with a fatty acid is  determined by the  struc- 
tural features of the substrate. When [3-'4C17,10,13,16-22:4 
was  incubated alone with peroxisomes, it  was  not possible to 
detect the accumulation of any radioactive 20- or 22-carbon 
intermediates  prior to the  first two P-ketothiolase steps. 
Hiltunen et al. (22) reported  that  tritium-labeled arachidonic 
acid was metabolized by peroxisomes into an undefined  product 
that they suggested was either 5,8-14:2 or 4,7,10-16:3. Our 
results  are  similar  to  theirs,  but we were  able to identify  4,7,10- 
16:3 and  present evidence that it was metabolized by fatty acid 
oxidase to 2-trans-4,7,10-16:4. 
[U-14C]9,12-18:2 was  chain-shortened via four cycles of P-oxi- 
dation  to yield 4-1O:l which also was metabolized by fatty acid 
oxidase to yield 2-trans-4-10:2. The most  noteworthy difference 
between the P-oxidation of linoleate versus arachidonate  was 
the accumulation of a  product  identified as 2-oxo-8,ll-heptade- 
cadienone. Most likely, this compound was formed by sponta- 
neous decarboxylation of 3-oxo-9,12-18:2 during saponification 
and  subsequent esterification  (26). The  rates of P-oxidation of 
[1-'4C]7,10,13,16-22:4 and [1-'4C19,12-18:2 as assayed by the 
production of acid-soluble radioactivity  were  similar. The pos- 
sible  accumulation of 3-oxo-9,12-18:2 but  not 3-oxo-7,10,13,16- 
22:4 suggests  that  the r action  catalyzed by P-ketothiolase may 
be a rate-controlling  reaction  in  the P-oxidation of linoleate as 
has previously  been reported for palmitate,  where 3-oxo-169 
accumulated (20). 
The  end products  detected from the P-oxidation of both lino- 
leate and arachidonate are the first metabolites that would 
require the NADPH-dependent 2-trans-4-cis-dienoyl-CoA re- 
ductase for continued P-oxidation. When Wigren et al. (27)  in- 
cubated 12-(S)-hydroxy-5,8,10,14-20:4 with liver peroxisomes, 
they detected 8-hydroxy-4,6,10-16:3 as  the  end catabolite which 
they suggested moved to mitochondria to complete the P-oxi- 
dation process. Neither  theirs  nor  our  incubations contained 
any NADPH. The accumulation of substrates for the 2,4-dien- 
oyl-CoA reductase  might  thus be due to  the absence of a  re- 
quired cofactor rather  than a block in  the P-oxidation spiral.  In 
recent studies, we have observed that the amount of acid- 
soluble  radioactivity produced from [1-14C14,7,10-16:3 and 
[1-'4C14,7,10,13,16-22:5 was relatively independent of exog- 
enous NADPH.3 It  thus  appears  that  the reaction  catalyzed by 
peroxisomal 2,4-dienoyl-CoA reductase  may be a rate-limiting 
step  but not an absolute metabolic block in removing double 
bonds from even-numbered  carbon atoms  in  polyunsaturated 
fatty acids. Recently, it  has been  shown that liver  mitochondria 
contain two isoforms of 2,4-dienoyl-CoA reductase while the 
peroxisomal enzyme is a different protein. Only about 10% 
of the total activity in liver is associated with peroxisomes 
when enzyme activity  was  assayed  using 2,4-hexadienoyl-CoA 
as  the  substrate (28). I t  is thus possible when substrates for 
the peroxisomal 2,4-dienoyl-CoA are produced that  they  are  in 
part  transported  to mitochondria to complete the P-oxidation 
process. 
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